Date and time
Thursday 20 March 2025, 10:00.
Venue
Bernicia House, The Waterfront, Goldcrest Way, Newcastle upon Tyne, NE15 8NY
If you require further information or need the meeting papers in a different format, please email kathryn.
Preliminary items
Verbal update
Verbal update
Verbal update
Public Board of Directors Meeting No.5 2024/25
Strategy and performance
Verbal update
This is a regular update from the Chief Executive of key actions and developments. The report includes internal developments within NEAS, as well as policy and influencing activity in the local system and nationally.
To provide Trust Board with an overview of key performance metrics covering quality and safety, clinical, operational performance, people and finance.
This paper provides the Board with the findings from the 2024 NHS Staff Survey results, and the next steps.
To assure the Trust Board on the progress of the Trust’s 2024/25 strategic objectives following a review at the end of Quarter 3.
The paper will highlight key updates and provide assurance on progress made on the 2024/25 strategic objectives and identify any risks, the actions taken and provide recommendations for mitigation.
The paper provides details of proposed Trust strategic objectives for 2025/6. These are based on previous feedback from Board members at a Board development session on 29th January 2025, as well as developmental work undertaken by Directors and their teams during February and March. Board members are asked to approve the 2025/6 strategic objectives and associated Objective Goals Initiatives Measures (OGIM) frameworks.
Quality & Safety
Presentation
Deferred to next meeting
Assurance Reports from Committees
Regulatory and governance
To consider and approve the paper and assessments on the Board Assurance Framework (BAF) as at Q3 as recommended by the Audit and Risk Committee on 11 February 2025.
Following the disbanding of Technology Committee its work was redistributed, with Audit and Risk Committee (ARC) now having responsibility for oversight and assurance going forwards. The Board is asked to approve the amended Terms of Reference for Audit and Risk Committee to accommodate these changes.
The Board is requested to approve the Terms of Reference for the Nomination & Remuneration Committee.
Nomination & Remuneration Committee Terms of Reference briefing paper
Concluding items
The Board is asked to note the Schedule of Business for 2025/26.
Schedule of Business 2025/26 briefing paper
Verbal
Verbal
Verbal
Verbal